NSC
53
-4
ALL
50
2
AEP
54
6
KMI
69
-2
CAH
48
-6
CRM
60
-7
ROST
57
-3
VMC
53
-4
OMC
50
-16
FFIV
66
-4
AVGO
18
-9
KLAC
38
-6
CAG
24
-3
EW
32
3
PDCO
29
2
SCHW
62
-2
KEY
43
-3
GLW
45
-3
CMG
66
-4
ZTS
47
2
NSC
53
-4
ALL
50
2
AEP
54
6
KMI
69
-2
CAH
48
-6
CRM
60
-7
ROST
57
-3
VMC
53
-4
OMC
50
-16
FFIV
66
-4
AVGO
18
-9
KLAC
38
-6
CAG
24
-3
EW
32
3
PDCO
29
2
SCHW
62
-2
KEY
43
-3
GLW
45
-3
CMG
66
-4
ZTS
47
2
Financhill
Back

Franklin FTSE South Korea ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
52

FLKR
Franklin FTSE South Korea ETF

Last Price:
18.71
Seasonality Move:
7.3%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
52
Franklin FTSE South Korea ETF (FLKR) is a Buy

Is Franklin FTSE South Korea ETF a Buy, Sell or Hold?

  • The current Franklin FTSE South Korea ETF [FLKR] share price is $18.71. The Score for FLKR is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • FLKR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FLKR Stock Price Chart

What is Franklin FTSE South Korea ETF's stock price today?

  • The Franklin FTSE South Korea ETF share price today is $18.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FLKR is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

FLKR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 31.49 Sell
Chaikin Money Flow: -8593 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.31 - 20.67) Sell
Bollinger Bands (100): (20.11 - 21.97) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

FLKR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.2 Sell
20-day SMA: 19.8 Sell
50-day SMA: 20.51 Sell
200-day SMA: 21.75 Sell
8-day EMA: 19.1 Sell
20-day EMA: 19.68 Sell
50-day EMA: 20.34 Sell
200-day EMA: 21.26 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Franklin FTSE South Korea ETF Earnings Growth & FLKR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Franklin FTSE South Korea ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):